Next, we sought to ascertain the correlation between high CD45+ CTCs percentage (CD45+ CTCshi defined as CD45+ CTC counts / total CTC counts ≥ 40% per 5 mL blood sample from each cancer patient) and metastasis. This evidence concerns the gene PTPRC and cancer.